Wednesday, 26 March 2014
Since the 2004 NEJM article investigating PONV, there have been several guidelines for the evaluation, prophylaxis, and management of PONV. This current article takes a more detailed re-evaluation of the subject, taking into consideration additional/newer studies and newer classes of anti-emetics.
The overall recommendations provide an improved and modified risk-scoring system and a few new directions in recommendations for specific pharmacologic therapy.
The utilization of antiemetics is (likely) one of the most common pharmacologic therapies given consistently across our perioperative patient population. Considering the significant proportion of our patient population, we would be remiss to not familiarize ourselves with these new guidelines. MD